Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cellsin vitroandin vivo

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

(2015) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells

(2015) Moshe Giladi et al.   Scientific Reports

Alternating Electric Fields (Tumor-Treating Fields Therapy) Can Improve Chemotherapy Treatment Efficacy in Non-Small Cell Lung Cancer Both In Vitro and In Vivo

(2014) Moshe Giladi et al.   SEMINARS IN ONCOLOGY

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) J. A. Ledermann et al.   ANNALS OF ONCOLOGY

A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer

(2013) Miklos Pless et al.   LUNG CANCER

Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields

(2013) Moshe Giladi et al.   PANCREATOLOGY

Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade

(2012) Willi Oberaigner et al.   ACTA ONCOLOGICA

Recent progress in the diagnosis and treatment of ovarian cancer

(2011) Danijela Jelovac et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

(2011) Timothy J. Perren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ovarian Cancer Development and Metastasis

(2010) Ernst Lengyel   AMERICAN JOURNAL OF PATHOLOGY

Ranking the Influence of Tissue Conductivities on Forward-Calculated ECGs

(2010) David U J Keller et al.   IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING

How do anti-mitotic drugs kill cancer cells?

(2009) K. E. Gascoigne et al.   JOURNAL OF CELL SCIENCE

Ovarian cancer

(2009) Bryan T Hennessy et al.   LANCET

Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis

(2008) Z N Demidenko et al.   ONCOGENE

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

(2008) Patrizia Vici et al.   ONCOLOGY